期刊文献+

VEGFA rs3025039 and biliary atresia susceptibility in Chinese population:a systematic review and meta-analysis

原文传递
导出
摘要 Background Previous studies have suggested an association between vascular endothelial growth factor A(VEGFA)rs3025039 polymorphism and biliary atresia(BA).However,this conclusion is controversial and there is no published pooled evidence of this association.Methods This study was conducted and reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses.The protocol was registered with PROSPERO(International Prospective Register of Systematic Reviews).A thorough search was performed on databases including PubMed,Embase,and Chinese Biomedical Database up to August 2020.This study included 846 cases of BA and 2821 controls concerning VEGFA rs3025039 polymorphism.We selected relevant studies based on the following inclusion criteria:(1)the study design was case-control and cohort and(2)the patients carried standard clinical diagnoses of BA,etc.The exclusion criteria were as follows:(1)patients with other related diseases,(2)lack of requisite information and(3)duplicate data.The OR(odd ratio)and the corresponding 95%CI(confidence interval)were calculated to estimate the association.Results This study on VEGFA rs3025039 polymorphism in the Chinese population included 846 cases and 2821 controls.The results showed that there was no significant association between rs3025039 and susceptibility to BA under four genetic models.The results of the subgroup analysis were similar to the overall results.Conclusions This meta-analysis shows that rs3025039 was not associated with susceptibility to BA in the Chinese population.Further validation may entail additional research.PROSPERO registration number CRD42020203812.
出处 《World Journal of Pediatric Surgery》 2022年第1期58-63,共6页 世界小儿外科杂志(英文)
基金 This study received financial support from the Clinical Research Plan of SHDC(no SHDC2020CR2009A) Shanghai Municipal Key Clinical Specialty(no shslczdzk05703) National Natural Science Foundation of China(no 81770519,no 81771633,no 81873545,and no 81974059) Science Foundation of Shanghai(no 18411969100 and no 19ZR1406600) Children's National Medical Center(no EK1125180104,no EKYY20180204,no EK112520180211,and no EK112520180310).
  • 相关文献

参考文献1

二级参考文献28

  • 1Salven P, Orpana A, Joensuu H. Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor. Clin Cancer Res 1999; 5:487-491.
  • 2Veikkola T, Alitalo K. VEGFs, receptors and angiogenesis.Semin Cancer Biol 1999; 9:211-220.
  • 3Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J1999; 13:9-22.
  • 4Linderholm B, Lindh B, Tavelin B, Grankvist K, HenrikssonR. p53 and vascular endothelial growth factor (VEGF) expression predicts outcome in 833 patients with primary breast carcinoma. Int J Cancer 2000; 89:51-62.
  • 5Toi M, Bando H, Ogawa T, Muta M, Hornig C, Weich HA.Significance of vascular endothelial growth factor (VEGF)/soluble VEGF receptor-1 relationship in breast cancer. Int J Cancer 2002; 98:14-18.
  • 6Kumar H, Heer K, Lee PW, Duthie GS, MacDonald AW,Greenman J, Kerin MJ, Monson JR. Preoperative serum vascular endothelial growth factor can predict stage in colorectal tumor. Clin Cancer Res 1998; 4:1279-1285.
  • 7George ML, Eccles SA, Tutton MG, Abulafi AM, Swift RI.Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer:Clinical evidence of platelet scavenging? Clin Cancer Res2000; 6:3147-3152.
  • 8Wartiovaara U, Salven P, Mikkola H, Lassila R, Kaukonen J,Joukov V, Orpana A, Ristimaki A, Heikinheimo M, JoensuuH, Alitalo K, Palotie A. A peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation. Thromb Haemost 1998; 80:171-175.
  • 9Maloney JP, Silliman CC, Ambruso DR, Wang J, Tuder RM,Voelkel NF. In vitro release of vascular endothelial growth factor during platelet aggregation. Am J Physiol 1998; 275(3 Pt 2): H1054-1061.
  • 10Webb NJ, Bottomley MJ, Watson CJ, Brenchley PE. Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: Implications for measurement of circulating VEGF levels in clinical disease. Clin Sci 1998; 94- 395-404.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部